P1078
Current StudyA Phase IV Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety (Hepatotoxicity) of Immediate (Antepartum-Initiated) vs. Deferred (Postpartum-Initiated) Isoniazid Preventive Therapy Among HIV-Infected Women in High TB incidence Set …
IMPAACT
More about this study »P1115
Current StudyVery Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof-of-Concept Study Sponsors: The National Institute of Allergy and Infectious Diseases (NIAD) The Eunice Kennedy Shriver National Institute of Child Heal …
IMPAACT
More about this study »The CHAPS Trial: Combined HIV Adolescent PrEP and Prevention
Current StudyStudy: The CHAPS Trial: Combined HIV Adolescent PrEP and Prevention Study Title: Combined HIV Adolescent PrEP and Prevention: On Demand Pre-exposure Prophylaxis to Provide Protection from HIV in Men – Using Foreskin Tissue to Estimate Protection (Phase …
IMPAACT
More about this study »P1093
Current StudyStudy Title: Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents Protocol summary: …
IMPAACT
More about this study »P1112
Current StudyStudy Title: Open-Label, Dose-Escalating, Phase I Study to Determine Safety and Pharmacokinetic Parameters of Subcutaneous (SC) VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants Protocol summ …
IMPAACT
More about this study »IMPAACT 2001
Current StudyStudy Title: A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-infected and HIV-1-uninfected Pregnant and Postpartum Women with Latent Tuberculosis Infection Protocol summary: IMPAAC …
IMPAACT
More about this study »IMPAACT 2008
Current StudyStudy Title: Phase I/II Multisite, Randomized, Controlled Study of Monoclonal Antibody VRC01 with Combination Antiretroviral Therapy to Promote Clearance of HIV-1-Infected Cells in Infants Protocol summary: IMPAACT 2008 is a Phase I/II, multisite, ran …
IMPAACT
More about this study »IMPAACT 2009
Current StudyStudy Title: Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for Primary HIV Prevention during Pregnancy and Postpartum in Adolescents and Young Women and their Infants Protocol summary: IMPAACT 2009 is a para …
IMPAACT
More about this study »IMPAACT 2010/VESTED
Current StudyStudy Title: Phase III Study of the Virologic Efficacy and Safety of Dolutegravir-Containing versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and their Infants Protocol summary: IMPAACT 2010 is a Phase III, …
IMPAACT
More about this study »IMPAACT 2016
Current StudyStudy Title: Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence Among Youth Living with HIV in Low Resource Settings Protocol summary: IMPAACT 2016 is a multi-site, two-arm, randomized, controlled study preceded by a feas …
IMPAACT
More about this study »IMPAACT 2026
Current StudyStudy Title: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum Protocol summary: IMPAACT 2026 is a Phase IV, prospective, pharmacokinetic (PK) study of selected antiretroviral (ARV) and anti-tuber …
IMPAACT
More about this study »IMPAACT 2028
Current StudyStudy Title: Long-Term Clinical, Immunologic, and Virologic Profiles of Children who Received Early Treatment for HIV Protocol summary: IMPAACT 2028 is an observational study to characterize a cohort of children who may participate in future research …
IMPAACT
More about this study »HPTN/IMPAACT 046
Completed StudyPhase III Trial to Determine the Efficacy and Safety of an Extended Regimen of Nevirapine in Infants Born to HIV Infected Women to Prevent Vertical HIV Transmission During Breastfeeding Sponsors: Division of AIDS, US National Institute of Allergy and I …
IMPAACT
More about this study »PEPFAR 046
Completed StudyIntegrating Family Planning into PMTCT: A Novel Approach in Zimbabwe (A Substudy of HPTN/IMPAACT 046) Sponsors: US National Institutes of Health (NIH) PEPFAR Protocol Summary: PEPFAR 046 sought to understand the feasibility and short-term effects of an …
IMPAACT
More about this study »P1060
Completed StudyPhase II, Parallel, Randomized, Clinical Trials Comparing the Responses to Initiation of NNRTI-Based Versus PI-Based Antiretroviral Therapy in HIV-Infected Infants Who Have and Have Not Previously Received Single Dose Nevirapine for Prevention of Mothe …
IMPAACT
More about this study »P1060
Completed StudyPhase II, Parallel, Randomized, Clinical Trials Comparing The Responses To Initiation of NNRTI-based Versus PI-Based Antiretroviral Therapy in HIV-Infected Infants Who Have And Have Not Previously Received Single Dose Nevirapine For Prevention of Mothe …
IMPAACT
More about this study »P1070
Completed StudyDose-Finding and Pharmacogenetic Study of Efavirenz in HIV-Infected and HIV/TB Co-Infected Infants and Children ≥ 3 Months to < 36 Months of Age Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy Shriver Na …
IMPAACT
More about this study »P1072
Completed StudySafety and Immunogenicity of a Live, Attenuated, Rotavirus Vaccine (ROTATEQTM) In HIV-Infected and Uninfected Children Born To HIV-Infected Mothers Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy Shriver Na …
IMPAACT
More about this study »P1073
Completed StudyStudy of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children < 72 months of Age Sponsors: US National Institute of Allergy and Infectious Diseases …
IMPAACT
More about this study »1077BF – PROMISE
Completed StudyPromoting Maternal and Infant Survival Everywhere (PROMISE) Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Protocol Summary: 1077BF …
IMPAACT
More about this study »P1084s
Completed StudyMaternal and Infant Monitoring for Evidence of Toxicity Related to Tenofovir Exposure: The Bone and Kidney Health Substudy of the IMPAACT 1077 PROMSE Protocol Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID) The Eunice Kennedy …
IMPAACT
More about this study »P1104s
Completed StudyLongitudinal Developmental and Neuropsychological Assessments of HIV infected Participants of P1060 and HIV Uninfected Sponsors: US National Institute of Allergy and Infectious Diseases (NIAD) The Eunice Kennedy Shriver National Institute of Child Heal …
IMPAACT
More about this study »
